{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:43:46Z","timestamp":1780343026318,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360132"],"award-info":[{"award-number":["82360132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lanzhou Science and Technology Plan Project","award":["2023-2-76"],"award-info":[{"award-number":["2023-2-76"]}]},{"name":"Gansu Clinical Medical Research Center of Infection & Liver Diseases","award":["21JR7RA392"],"award-info":[{"award-number":["21JR7RA392"]}]},{"name":"Gansu Province Education Science and Technology Innovation Program","award":["ZX-62000002-2021-226"],"award-info":[{"award-number":["ZX-62000002-2021-226"]}]},{"name":"FY 2021 Special Fund for Artificial Liver","award":["RGGJJ-2021-004"],"award-info":[{"award-number":["RGGJJ-2021-004"]}]},{"name":"Gansu Provincial Key R&D Program Projects","award":["24YFFA037"],"award-info":[{"award-number":["24YFFA037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00210-024-03710-7","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T09:55:39Z","timestamp":1734342939000},"page":"4875-4889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disulfiram in liver diseases: a double-edged sword"],"prefix":"10.1007","volume":"398","author":[{"given":"Wanyuan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"3710_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s13311-019-00802-8","volume":"17","author":"G Addolorato","year":"2020","unstructured":"Addolorato G, Vassallo GA, Mirijello A, Gasbarrini A (2020) Diagnosis and management of alcohol use disorder in patients with liver disease: lights and shadows. Neurotherapeutics 17:127\u2013141","journal-title":"Neurotherapeutics"},{"key":"3710_CR2","doi-asserted-by":"publisher","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","volume":"1873","author":"D Anwanwan","year":"2020","unstructured":"Anwanwan D, Singh SK, Singh S, Saikam V, Singh R (2020) Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer 1873:188314","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3710_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/03639045.2023.2216785","volume":"49","author":"RM Ardad","year":"2023","unstructured":"Ardad RM, Manjappa AS, Dhawale SC, Kumbhar PS, Pore YV (2023) Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma. Drug Dev Ind Pharm 49:377\u2013391","journal-title":"Drug Dev Ind Pharm"},{"key":"3710_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70:151\u2013171","journal-title":"J Hepatol"},{"key":"3710_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/00365521.2016.1267790","volume":"52","author":"M Baekdal","year":"2017","unstructured":"Baekdal M, Ytting H, Skalsh\u00f8i Kj\u00e6r M (2017) Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period. Scand J Gastroenterol 52:450\u2013454","journal-title":"Scand J Gastroenterol"},{"key":"3710_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0009-2797(01)00283-6","volume":"138","author":"MY Balakirev","year":"2001","unstructured":"Balakirev MY, Zimmer G (2001) Mitochondrial injury by disulfiram: two different mechanisms of the mitochondrial permeability transition. Chem Biol Interact 138:299\u2013311","journal-title":"Chem Biol Interact"},{"key":"3710_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/BF01309513","volume":"30","author":"WR Bartle","year":"1985","unstructured":"Bartle WR, Fisher MM, Kerenyi N (1985) Disulfiram-induced hepatitis. Report of two cases and review of the literature. Dig Dis Sci 30:834\u2013837","journal-title":"Dig Dis Sci"},{"key":"3710_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD (2021) Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer 21:526\u2013536","journal-title":"Nat Rev Cancer"},{"key":"3710_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cmet.2020.04.019","volume":"32","author":"M Bernier","year":"2020","unstructured":"Bernier M, Mitchell SJ, Wahl D, Diaz A, Singh A, Seo W, Wang M, Ali A, Kaiser T, Price NL, Aon MA, Kim EY, Petr MA, Cai H, Warren A, Di Germanio C, Di Francesco A, Fishbein K, Guiterrez V, Harney D, Koay YC, Mach J, Enamorado IN, Pulpitel T, Wang Y, Zhang J, Zhang L, Spencer RG, Becker KG, Egan JM, Lakatta EG, O\u2019Sullivan J, Larance M, LeCouteur DG, Cogger VC, Gao B, Fernandez-Hernando C, Cuervo AM, de Cabo R (2020) Disulfiram treatment normalizes body weight in obese mice. Cell Metab 32:203-214.e4","journal-title":"Cell Metab"},{"key":"3710_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2005.12.016","volume":"44","author":"E Bj\u00f6rnsson","year":"2006","unstructured":"Bj\u00f6rnsson E, Nordlinder H, Olsson R (2006) Clinical characteristics and prognostic markers in disulfiram-induced liver injury. J Hepatol 44:791\u2013797","journal-title":"J Hepatol"},{"key":"3710_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3710_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.medcli.2021.04.011","volume":"158","author":"M Celada-Sendino","year":"2022","unstructured":"Celada-Sendino M, \u00c1lvarez-Navascu\u00e9s C, Rodr\u00edguez M (2022) Disulfiram hepatotoxicity: report of three cases. Med Clin (Barc) 158(3):145\u2013146","journal-title":"Med Clin (Barc)"},{"key":"3710_CR13","doi-asserted-by":"publisher","first-page":"860225","DOI":"10.3389\/fimmu.2022.860225","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Zhou YK, Han CS, Chen LJ, Wang YM, Zhuang ZM, Lin S, Zhou YH, Jiang JH, Yang RL (2022) Stem cells from human exfoliated deciduous teeth alleviate liver cirrhosis via inhibition of gasdermin D-executed hepatocyte pyroptosis. Front Immunol 13:860225","journal-title":"Front Immunol"},{"key":"3710_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2165\/00002018-199920050-00003","volume":"20","author":"J Chick","year":"1999","unstructured":"Chick J (1999) Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 20:427\u2013435","journal-title":"Drug Saf"},{"key":"3710_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS (2023) Global burden of liver disease: 2023 update. J Hepatol 79:516\u2013537","journal-title":"J Hepatol"},{"key":"3710_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.7326\/0003-4819-83-5-673_2","volume":"83","author":"HJ Eisen","year":"1975","unstructured":"Eisen HJ, Ginsberg AL (1975) Letter: Disulfiram hepatotoxicity. Ann Intern Med 83:673\u2013675","journal-title":"Ann Intern Med"},{"key":"3710_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0168-8278(98)80264-X","volume":"29","author":"E Eliasson","year":"1998","unstructured":"Eliasson E, St\u00e5l P, Oksanen A, Lytton S (1998) Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis. J Hepatol 29:819\u2013825","journal-title":"J Hepatol"},{"key":"3710_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-0447.1992.tb03317.x","volume":"369","author":"H Enghusen Poulsen","year":"1992","unstructured":"Enghusen Poulsen H, Loft S, Andersen JR, Andersen M (1992) Disulfiram therapy\u2013adverse drug reactions and interactions. Acta Psychiatr Scand Suppl 369:59\u201365 (discussion 65-66)","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"3710_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67:123\u2013133","journal-title":"Hepatology"},{"key":"3710_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eatbeh.2014.10.008","volume":"16","author":"AM Farci","year":"2015","unstructured":"Farci AM, Piras S, Murgia M, Chessa A, Restivo A, Gessa GL, Agabio R (2015) Disulfiram for binge eating disorder: an open trail. Eat Behav 16:84\u201387","journal-title":"Eat Behav"},{"issue":"5","key":"3710_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0168-8278(94)80249-1","volume":"21","author":"X Forns","year":"1994","unstructured":"Forns X, Caballer\u00eda J, Bruguera M et al (1994) Disulfiram-induced hepatitis. Report of four cases and review of the literature. J Hepatol. 21(5):853\u20137","journal-title":"J Hepatol."},{"key":"3710_CR22","doi-asserted-by":"publisher","first-page":"10502","DOI":"10.1074\/jbc.M114.553123","volume":"289","author":"A Galkin","year":"2014","unstructured":"Galkin A, Kulakova L, Lim K, Chen CZ, Zheng W, Turko IV, Herzberg O (2014) Structural basis for inactivation of giardia lamblia carbamate kinase by disulfiram. J Biol Chem 289:10502\u201310509","journal-title":"J Biol Chem"},{"key":"3710_CR23","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.3390\/cancers14194715","volume":"14","author":"X Gao","year":"2022","unstructured":"Gao X, Huang H, Pan C, Mei Z, Yin S, Zhou L, Zheng S (2022) Disulfiram\/copper induces immunogenic cell death and enhances Cd47 blockade in hepatocellular carcinoma. Cancers (Basel) 14:4715","journal-title":"Cancers (Basel)"},{"key":"3710_CR24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2019","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2019) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"key":"3710_CR25","doi-asserted-by":"publisher","first-page":"18821","DOI":"10.18632\/oncotarget.24568","volume":"9","author":"K Goto","year":"2018","unstructured":"Goto K, Arai J, Stephanou A, Kato N (2018) Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10. Oncotarget 9:18821\u201318831","journal-title":"Oncotarget"},{"key":"3710_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.15288\/jsa.1979.40.133","volume":"40","author":"PF Goyer","year":"1979","unstructured":"Goyer PF, Major LF (1979) Hepatotoxicity in disulfiram-treated patients. J Stud Alcohol 40:133\u2013137","journal-title":"J Stud Alcohol"},{"key":"3710_CR27","doi-asserted-by":"publisher","first-page":"9897315","DOI":"10.1155\/2019\/9897315","volume":"2019","author":"I Hassan","year":"2019","unstructured":"Hassan I, Ebaid H, Alhazza IM, Al-Tamimi J, Aman S, Abdel-Mageed AM (2019) Copper mediates anti-inflammatory and antifibrotic activity of Gleevec in hepatocellular carcinoma-induced male rats. Can J Gastroenterol Hepatol 2019:9897315","journal-title":"Can J Gastroenterol Hepatol"},{"key":"3710_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R (2023) Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol 20:37\u201349","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3710_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0041-008X(86)90059-1","volume":"86","author":"OJ Igwe","year":"1986","unstructured":"Igwe OJ, Hee SS, Wagner WD (1986) Interaction between 1,2-dichloroethane and tetraethylthiuram disulfide (disulfiram). II. Hepatotoxic manifestations with possible mechanism of action. Toxicol Appl Pharmacol 86:286\u2013297","journal-title":"Toxicol Appl Pharmacol"},{"key":"3710_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","volume":"369","author":"B Johansson","year":"1992","unstructured":"Johansson B (1992) A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 369:15\u201326","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"3710_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/pharmaceutics16010065","volume":"16","author":"A Kaya","year":"2023","unstructured":"Kaya A, Arafat B, Chichger H, Tolaymat I, Pierscionek B, Khoder M, Najlah M (2023) Preparation and characterisation of zinc diethyldithiocarbamate-cyclodextrin inclusion complexes for potential lung cancer treatment. Pharmaceutics 16:65","journal-title":"Pharmaceutics"},{"key":"3710_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0090-9556(24)15310-X","volume":"27","author":"ED Kharasch","year":"1999","unstructured":"Kharasch ED, Hankins DC, Jubert C, Thummel KE, Taraday JK (1999) Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1. Drug Metab Dispos 27:717\u2013723","journal-title":"Drug Metab Dispos"},{"key":"3710_CR33","first-page":"524","volume":"12","author":"J Lanz","year":"2023","unstructured":"Lanz J, Biniaz-Harris N, Kuvaldina M, Jain S, Lewis K, Fallon BA (2023) Disulfiram: mechanisms, applications, and challenges. Antibiotics (Basel, Switzerland) 12:524","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"3710_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21037\/jgo.2017.06.08","volume":"9","author":"S Lee","year":"2018","unstructured":"Lee S, Loecher M, Iyer R (2018) Immunomodulation in hepatocellular cancer. J Gastrointest Oncol 9:208\u2013219","journal-title":"J Gastrointest Oncol"},{"key":"3710_CR35","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1038\/s41467-022-34671-1","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei Y, Tang L, Chen Q, Wu L, He W, Tu D, Wang S, Chen Y, Liu S, Xie Z, Wei H, Yang S, Tang B (2022) Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism. Nat Commun 13:6862","journal-title":"Nat Commun"},{"key":"3710_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/jcmm.13334","volume":"22","author":"Y Li","year":"2018","unstructured":"Li Y, Wang LH, Zhang HT, Wang YT, Liu S, Zhou WL, Yuan XZ, Li TY, Wu CF, Yang JY (2018) Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the Nf-\u03baB and Tgf-\u03b2 pathways. J Cell Mol Med 22:439\u2013451","journal-title":"J Cell Mol Med"},{"key":"3710_CR37","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","volume":"25","author":"H Li","year":"2020","unstructured":"Li H, Wang J, Wu C, Wang L, Chen ZS, Cui W (2020a) The combination of disulfiram and copper for cancer treatment. Drug Discov Today 25:1099\u20131108","journal-title":"Drug Discov Today"},{"key":"3710_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/cancers12010138","volume":"12","author":"Y Li","year":"2020","unstructured":"Li Y, Chen F, Chen J, Chan S, He Y, Liu W, Zhang G (2020b) Disulfiram\/copper induces antitumor activity against both nasopharyngeal cancer cells and cancer-associated fibroblasts through Ros\/MAPK and ferroptosis pathways. Cancers (Basel) 12:138","journal-title":"Cancers (Basel)"},{"key":"3710_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00280-022-04481-9","volume":"90","author":"H Lin","year":"2022","unstructured":"Lin H, Sun F, Li T, Zhang Y, Guo X, Li M, Liang M, Zhou X, Fang Z (2022) Disulfiram enhances chemotherapeutic effects of doxorubicin liposomes against human hepatocellular carcinoma via activating Ros-induced cell stress response pathways. Cancer Chemother Pharmacol 90:455\u2013465","journal-title":"Cancer Chemother Pharmacol"},{"key":"3710_CR40","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1111\/bph.14503","volume":"175","author":"T Liu","year":"2018","unstructured":"Liu T, Wang P, Cong M, Zhao X, Zhang D, Xu H, Liu L, Jia J, You H (2018) Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress. Br J Pharmacol 175:4480\u20134495","journal-title":"Br J Pharmacol"},{"key":"3710_CR41","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms22105170","volume":"22","author":"SY Liu","year":"2021","unstructured":"Liu SY, Tsai IT, Hsu YC (2021) Alcohol-related liver disease: basic mechanisms and clinical perspectives. Int J Mol Sci 22:5170","journal-title":"Int J Mol Sci"},{"key":"3710_CR42","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1080\/21655979.2022.2038434","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Guan X, Wang M, Wang N, Chen Y, Li B, Xu Z, Fu F, Zheng Z, Du C (2022) Disulfiram\/copper induces antitumor activity against gastric cancer via the Ros\/MAPK and Npl4 pathways. Bioengineered 13:6579\u20136589","journal-title":"Bioengineered"},{"key":"3710_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00280-020-04216-8","volume":"87","author":"C Lu","year":"2021","unstructured":"Lu C, Li X, Ren Y, Zhang X (2021) Disulfiram: a novel repurposed drug for cancer therapy. Cancer Chemother Pharmacol 87:159\u2013172","journal-title":"Cancer Chemother Pharmacol"},{"key":"3710_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","volume":"1","author":"J Luther","year":"2015","unstructured":"Luther J, Garber JJ, Khalili H, Dave M, Bale SS, Jindal R, Motola DL, Luther S, Bohr S, Jeoung SW, Deshpande V, Singh G, Turner JR, Yarmush ML, Chung RT, Patel SJ (2015) Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability. Cell Mol Gastroenterol Hepatol 1:222\u2013232","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3710_CR45","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM (2016) Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150:1769\u20131777","journal-title":"Gastroenterology"},{"key":"3710_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.chom.2016.10.016","volume":"20","author":"AJ Macpherson","year":"2016","unstructured":"Macpherson AJ, Heikenwalder M, Ganal-Vonarburg SC (2016) The liver at the nexus of host-microbial interactions. Cell Host Microbe 20:561\u2013571","journal-title":"Cell Host Microbe"},{"key":"3710_CR47","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1177\/106002808902301107","volume":"23","author":"NA Mason","year":"1989","unstructured":"Mason NA (1989) Disulfiram-induced hepatitis: case report and review of the literature. DICP 23:872\u2013875","journal-title":"DICP"},{"key":"3710_CR48","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3748\/wjg.v25.i19.2279","volume":"25","author":"OO Ogunwobi","year":"2019","unstructured":"Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT (2019) Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol 25:2279\u20132293","journal-title":"World J Gastroenterol"},{"key":"3710_CR49","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/aps.2013.52","volume":"34","author":"HJ Park","year":"2013","unstructured":"Park HJ, Kim MS, Cho K, Yun JH, Choi YJ, Cho CH (2013) Disulfiram deregulates Hif-\u03b1 subunits and blunts tumor adaptation to hypoxia in hepatoma cells. Acta Pharmacol Sin 34:1208\u20131216","journal-title":"Acta Pharmacol Sin"},{"key":"3710_CR50","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1124\/dmd.110.034710","volume":"38","author":"M Pratt-Hyatt","year":"2010","unstructured":"Pratt-Hyatt M, Lin HL, Hollenberg PF (2010) Mechanism-based inactivation of human Cyp2e1 by diethyldithocarbamate. Drug Metab Dispos 38:2286\u20132292","journal-title":"Drug Metab Dispos"},{"key":"3710_CR51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","volume":"151","author":"K Rahman","year":"2016","unstructured":"Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y, Smith T, Neish AS, Li H, Tan S, Wu P, Liu X, Yu Y, Farris AB, Nusrat A, Parkos CA, Anania FA (2016) Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol. Gastroenterology 151:733-746.e12","journal-title":"Gastroenterology"},{"key":"3710_CR52","doi-asserted-by":"publisher","first-page":"8835647","DOI":"10.1155\/2020\/8835647","volume":"2020","author":"L Ramer","year":"2020","unstructured":"Ramer L, Tihy M, Goossens N, Frossard JL, Rubbia-Brandt L, Spahr L (2020) Disulfiram-induced acute liver injury. Case Reports Hepatol 2020:8835647","journal-title":"Case Reports Hepatol"},{"key":"3710_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/bmj.2.6079.94","volume":"2","author":"L Ranek","year":"1977","unstructured":"Ranek L, Buch Andreasen P (1977) Disulfiram hepatotoxicity. Br Med J 2:94\u201396","journal-title":"Br Med J"},{"key":"3710_CR54","doi-asserted-by":"publisher","first-page":"115642","DOI":"10.1016\/j.taap.2021.115642","volume":"426","author":"E Read","year":"2021","unstructured":"Read E, Milford J, Zhu J, Wu L, Bilodeau M, Yang G (2021) The interaction of disulfiram and H(2)S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth. Toxicol Appl Pharmacol 426:115642","journal-title":"Toxicol Appl Pharmacol"},{"key":"3710_CR55","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.redox.2021.102122","volume":"46","author":"X Ren","year":"2021","unstructured":"Ren X, Li Y, Zhou Y, Hu W, Yang C, Jing Q, Zhou C, Wang X, Hu J, Wang L, Yang J, Wang H, Xu H, Li H, Tong X, Wang Y, Du J (2021) Overcoming the compensatory elevation of Nrf2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis. Redox Biol 46:102122","journal-title":"Redox Biol"},{"key":"3710_CR56","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-G\u00f3mez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79:1542\u20131556","journal-title":"J Hepatol"},{"key":"3710_CR57","doi-asserted-by":"publisher","first-page":"G1135","DOI":"10.1152\/ajpgi.2001.281.5.G1135","volume":"281","author":"G Robertson","year":"2001","unstructured":"Robertson G, Leclercq I, Farrell GC (2001) Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281:G1135-1139","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3710_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ijcp.12764","volume":"70","author":"V Rosato","year":"2016","unstructured":"Rosato V, Abenavoli L, Federico A, Masarone M, Persico M (2016) Pharmacotherapy of alcoholic liver disease in clinical practice. Int J Clin Pract 70:119\u2013131","journal-title":"Int J Clin Pract"},{"key":"3710_CR59","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.76.10.5303","volume":"76","author":"LW Scheibel","year":"1979","unstructured":"Scheibel LW, Adler A, Trager W (1979) Tetraethylthiuram disulfide (Antabuse) inhibits the human malaria parasite Plasmodium falciparum. Proc Natl Acad Sci USA 76:5303\u20135307","journal-title":"Proc Natl Acad Sci USA"},{"key":"3710_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H (2018) Alcoholic liver disease. Nat Rev Dis Primers 4:16","journal-title":"Nat Rev Dis Primers"},{"key":"3710_CR61","unstructured":"Stokes M, Patel P, Abdijadid S (2024) Disulfiram. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)"},{"key":"3710_CR62","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.3748\/wjg.v12.i31.5078","volume":"12","author":"C Verge","year":"2006","unstructured":"Verge C, Lucena MI, L\u00f3pez-Torres E, Puche-Garcia MJ, Fraga E, Romero-Gomez M, Andrade RJ (2006) Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs. World J Gastroenterol 12:5078\u20135080","journal-title":"World J Gastroenterol"},{"key":"3710_CR63","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jat.2550110513","volume":"11","author":"R Von Burg","year":"1991","unstructured":"Von Burg R, Stout T (1991) Acetaldehyde. J Appl Toxicol 11:373\u2013376","journal-title":"J Appl Toxicol"},{"key":"3710_CR64","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.nano.2016.08.001","volume":"13","author":"Z Wang","year":"2017","unstructured":"Wang Z, Tan J, McConville C, Kannappan V, Tawari PE, Brown J, Ding J, Armesilla AL, Irache JM, Mei QB, Tan Y, Liu Y, Jiang W, Bian XW, Wang W (2017) Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells. Nanomedicine (Lond) 13:641\u2013657","journal-title":"Nanomedicine (Lond)"},{"key":"3710_CR65","first-page":"430","volume":"49","author":"C Wright 4th","year":"1988","unstructured":"Wright C 4th, Vafier JA, Lake CR (1988) Disulfiram-induced fulminating hepatitis: guidelines for liver-panel monitoring. J Clin Psychiatry 49:430\u2013434","journal-title":"J Clin Psychiatry"},{"key":"3710_CR66","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1039\/D2BM00803C","volume":"10","author":"PY Wu","year":"2022","unstructured":"Wu PY, Shen ZC, Jiang JL, Zhang BC, Zhang WZ, Zou JJ, Lin JF, Li C, Shao JW (2022) A multifunctional theranostics nanosystem featuring self-assembly of alcohol-abuse drug and photosensitizers for synergistic cancer therapy. Biomater Sci 10:6267\u20136281","journal-title":"Biomater Sci"},{"key":"3710_CR67","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","volume":"71","author":"J Xiao","year":"2019","unstructured":"Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, Xu Y, Liu Y, Li W, Koike K, He W, You H, Miao Y, Liu X, Meng M, Gao B, Wang H, Li C (2019) Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol 71:212\u2013221","journal-title":"J Hepatol"},{"key":"3710_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40360-022-00583-5","volume":"23","author":"XM Yang","year":"2022","unstructured":"Yang XM, Wu Z, Wang X, Zhou Y, Zhu L, Li D, Nie HZ, Wang YH, Li J, Ma X (2022) Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability. BMC Pharmacol Toxicol 23:54","journal-title":"BMC Pharmacol Toxicol"},{"key":"3710_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73\u201384","journal-title":"Hepatology"},{"key":"3710_CR70","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1055\/s-2008-1059461","volume":"118","author":"G Zala","year":"1993","unstructured":"Zala G, Schmid M, B\u00fchler H (1993) Fulminant hepatitis caused by disulfiram. Dtsch Med Wochenschr 118:1355\u20131360","journal-title":"Dtsch Med Wochenschr"},{"key":"3710_CR71","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2017.09.027","volume":"113","author":"K Zhang","year":"2017","unstructured":"Zhang K, Dong R, Sun K, Wang X, Wang J, Yang CS, Zhang J (2017) Synergistic toxicity of epigallocatechin-3-gallate and diethyldithiocarbamate, a lethal encounter involving redox-active copper. Free Radic Biol Med 113:143\u2013156","journal-title":"Free Radic Biol Med"},{"key":"3710_CR72","doi-asserted-by":"publisher","first-page":"913736","DOI":"10.3389\/fonc.2022.913736","volume":"12","author":"G Zhang","year":"2022","unstructured":"Zhang G, Wang Y, Fuchs BC, Guo W, Drum DL, Erstad DJ, Shi B, DeLeo AB, Zheng H, Cai L, Zhang L, Tanabe KK, Wang X (2022) Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram. Front Oncol 12:913736","journal-title":"Front Oncol"},{"key":"3710_CR73","first-page":"2442","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou B, Guo L, Zhang B, Liu S, Zhang K, Yan J, Zhang W, Yu M, Chen Z, Xu Y, Xiao Y, Zhou J, Fan J, Li H, Ye Q (2019) Disulfiram combined with copper induces immunosuppression via Pd-l1 stabilization in hepatocellular carcinoma. Am J Cancer Res 9:2442\u20132455","journal-title":"Am J Cancer Res"},{"key":"3710_CR74","doi-asserted-by":"publisher","first-page":"115441","DOI":"10.1016\/j.bcp.2023.115441","volume":"209","author":"H Zhou","year":"2023","unstructured":"Zhou H, Tan L, Liu B, Guan XY (2023) Cancer stem cells: recent insights and therapies. Biochem Pharmacol 209:115441","journal-title":"Biochem Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03710-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T20:01:56Z","timestamp":1744315316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03710-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03710-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}